CAF vs. CMF Combination Chemotherapy in Advanced Breast Cancer Patients

International Journal of Science and Research (IJSR)
doi 10.21275/v5i4.nov162901
Full Text
Abstract

Available in full text

Date
Authors

Unknown

Publisher

International Journal of Science and Research

Related search

Survival in Advanced Breast Cancer Combination Chemotherapy Improves Outlook

BMJ
1994English

Combination Chemotherapy in Metastatic Breast Cancer

BMJ
1977English

Combination Chemotherapy in Metastatic Breast Cancer

InPharma
1977English

Chemotherapy With CMF for Triple-Negative Breast Cancer With Carcinoma Erysipelatoides

JAMA Dermatology
DermatologyMedicine
2016English

Subclinical Cardiotoxicity Following Adjuvant Dose-Escalated FEC, High-Dose Chemotherapy, or CMF in Breast Cancer

British Journal of Cancer
Cancer ResearchOncology
2000English

Sequential Adriamycin and CMF in Metastatic Breast Cancer

Oncologist
Cancer ResearchMedicineOncology
1997English

Impact of Body Fat Distribution on Neoadjuvant Chemotherapy Outcomes in Advanced Breast Cancer Patients

Cancer Medicine
Cancer ResearchNuclear MedicineRadiologyImagingOncology
2015English

Outcomes of Advanced Gastric Cancer in Young Adult Patients Treated With First-Line Combination Chemotherapy

International Journal of Cancer Therapy and Oncology
2015English

Triplet Chemotherapy Combination With Cisplatin, Gemcitabine and Docetaxel in Patients With Chemotherapy‑naive Advanced Non-Small Cell Lung Cancer

Oncology Letters
Cancer ResearchOncology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy